Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer

被引:45
作者
Uddin, Nizam [1 ]
Kim, Rae-Kwon [1 ]
Yoo, Ki-Chun [1 ]
Kim, Young-Heon [1 ]
Cui, Yan-Hong [1 ]
Kim, In-Gyu [2 ]
Suh, Yongjoon [1 ]
Lee, Su-Jae [1 ]
机构
[1] Hanyang Univ, Dept Life Sci, Res Inst Nat Sci, Seoul 133791, South Korea
[2] Korea Atom Energy Res Inst, Environm Radiat Res Grp, Dept Radiat Biol, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
Cytokines; epithelial-mesenchymal transition; PIM2; positive feedback loop; STAT3; STEM-CELL ACTIVITY; PATHWAY; KINASES; EMT; TUMORIGENESIS; METASTASIS; MECHANISMS; EXPRESSION; RECEPTORS; PROTEINS;
D O I
10.1111/cas.12668
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis of breast cancer is promoted by epithelial-mesenchymal transition (EMT). Emerging evidence suggests that STAT3 is a critical signaling node in EMT and is constitutively activated in many carcinomas, including breast cancer. However, its signaling mechanisms underlying persistent activation of STAT3 associated with EMT remain obscure. Here, we report that PIM2 promotes activation of STAT3 through induction of cytokines. Activation of STAT3 caused an increase in PIM2 expression, implicating a positive feedback loop between PIM2 and STAT3. In agreement, targeting of either PIM2, STAT3 or PIM2-dependent cytokines suppressed EMT-associated migratory and invasive properties through inhibition of ZEB1. Taken together, our findings identify the signaling mechanisms underlying the persistent activation of STAT3 and the oncogenic role of PIM2 in EMT in breast cancer.
引用
收藏
页码:718 / 725
页数:8
相关论文
共 30 条
[1]   MOLECULAR-CLONING OF APRF, A NOVEL IFN-STIMULATED GENE FACTOR-3 P91-RELATED TRANSCRIPTION FACTOR INVOLVED IN THE GP130-MEDIATED SIGNALING PATHWAY [J].
AKIRA, S ;
NISHIO, Y ;
INOUE, M ;
WANG, XJ ;
WEI, S ;
MATSUSAKA, T ;
YOSHIDA, K ;
SUDO, T ;
NARUTO, M ;
KISHIMOTO, T .
CELL, 1994, 77 (01) :63-71
[2]   The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions [J].
Apte, Ron N. ;
Dotan, Shahar ;
Elkabets, Moshe ;
White, Malka R. ;
Reich, Eli ;
Carmi, Yaron ;
Song, Xiaping ;
Dvozkin, Tatyana ;
Krelin, Yakov ;
Voronov, Elena .
CANCER AND METASTASIS REVIEWS, 2006, 25 (03) :387-408
[3]   Stat3 Mediates Expression of Autotaxin in Breast Cancer [J].
Azare, Janeen ;
Doane, Ashley ;
Leslie, Kenneth ;
Chang, Qing ;
Berishaj, Marjan ;
Nnoli, Jennifer ;
Mark, Kevin ;
Al-Ahmadie, Hikmat ;
Gerald, William ;
Hassimi, Maryam ;
Viale, Agnes ;
Stracke, Mary ;
Lyden, David ;
Bromberg, Jacqueline .
PLOS ONE, 2011, 6 (11)
[4]   The serine/threonine kinase pim-1 [J].
Bachmann, M ;
Möröy, T .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (04) :726-730
[5]   Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer [J].
Berishaj, Marjan ;
Gao, Sizhi Paul ;
Ahmed, Simi ;
Leslie, Kenneth ;
Al-Ahmadie, Hikmat ;
Gerald, William L. ;
Bornmann, William ;
Bromberg, Jacqueline F. .
BREAST CANCER RESEARCH, 2007, 9 (03)
[6]   Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury [J].
Bertini, R ;
Allegretti, M ;
Bizzarri, C ;
Moriconi, A ;
Locati, M ;
Zampella, G ;
Cervellera, MN ;
Di Cioccio, V ;
Cesta, MC ;
Galliera, E ;
Martinez, FO ;
Di Bitondo, R ;
Troiani, G ;
Sabbatini, V ;
D'Anniballe, G ;
Anacardio, R ;
Cutrin, JC ;
Cavalieri, B ;
Mainiero, F ;
Strippoli, R ;
Villa, P ;
Di Girolamo, M ;
Martin, F ;
Gentile, M ;
Santoni, A ;
Corda, D ;
Poli, G ;
Mantovani, A ;
Ghezzi, P ;
Colotta, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11791-11796
[7]   PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers [J].
Brault, Laurent ;
Gasser, Christelle ;
Bracher, Franz ;
Huber, Kilian ;
Knapp, Stefan ;
Schwaller, Juerg .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (06) :1004-1015
[8]  
Brocker Chad, 2010, Human Genomics, V5, P30
[9]   Stat proteins and oncogenesis [J].
Bromberg, J .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) :1139-1142
[10]  
Buettner R, 2002, CLIN CANCER RES, V8, P945